Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 301-310 of 1757 for

Edit search filters
  1. MUC1 TCell receptor repertoire

    Rochester, MN

  2. A Study To Evaluate The Safety And Effectiveness Of TT-00420 In Adults With Advanced Cholangiocarcinoma

    Rochester, MN

  3. Study Of Magrolimab Combination Therapy To Treat Unresectable, Locally Advanced Or Metastatic Triple-Negative Breast Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  4. A Study Evaluating The Safety, Efficacy, And Pharmacokinetics Of Mosunetuzumab And A Combined Regimen Of Mosunetuzumab And Venetoclax In Participants With Relapsed Or Refractory Chronic Lymphocytic Leukemia

    Rochester, MN

  5. Study Of Cabozantinib Combined With Atezolizumab Vs. Second Novel Hormonal Therapy In Subjects With Metastatic Castration-Resistant Prostate Cancer

    Rochester, MN

  6. Taletrectinib Phase 2 Global Study In ROS1 Positive NSCLC

    Rochester, MN

  7. Low-Dose Selinexor And Choline Salicylate For The Treatment Of Patients With Non-Hodgkin Lymphoma Or Histiocytic/Dendritic Cell Neoplasms

    Rochester, MN

  8. A Study To Evaluate 68Ga- PSMA-Dual Contrast PET/MRI And PET/CT For Hepatocellular Carcinoma

    Rochester, MN

  9. A Study To Evaluate Durvalumab Plus Topotecan Or Lurbinectedin In Patients With Small Cell Lung Cancer

    Rochester, MN

  10. Rifaximin For The Treatment Of Gastrointestinal Toxicities Related To Pertuzumab-Based Therapy In Patients With Stage I-III HER2 Positive Breast Cancer

    Jacksonville, FL

.

Mayo Clinic Footer